Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Karin Waldner-Knogler"'
Autor:
Monika Lutters, Valérie Benelli, Chantal Csajka, Marco Giacomo Ceppi, Angela Lisibach, Karin Waldner-Knogler
Publikováno v:
European Journal of Clinical Pharmacology, 77 (2)
European Journal of Clinical Pharmacology
European journal of clinical pharmacology, vol. 77, no. 2, pp. 147-162
European Journal of Clinical Pharmacology
European journal of clinical pharmacology, vol. 77, no. 2, pp. 147-162
Purpose Older people are at risk of anticholinergic side effects due to changes affecting drug elimination and higher sensitivity to drug’s side effects. Anticholinergic burden scales (ABS) were developed to quantify the anticholinergic drug burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7b84874a6c8102de01cc407b5bab1f2
https://hdl.handle.net/20.500.11850/446015
https://hdl.handle.net/20.500.11850/446015
Autor:
Susan Cohrs, Karin Waldner-Knogler, Alexander Hohn, Ilse Novak-Hofer, Eliane Fischer, Kurt Zimmermann, Jürgen Grünberg, Roger Schibli, Simone Jeger
Publikováno v:
International Journal of Cancer. 130:2715-2721
The L1-cell adhesion molecule (L1-CAM) is highly expressed in various cancer types including ovarian carcinoma but is absent from most normal tissue. A chimeric monoclonal antibody, chCE7, specifically binds to human L1-CAM and exhibits anti-prolifer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c23f4bcdbe04aeaa9c6f659f98c34b
https://doi.org/10.1002/ijc.26321
https://doi.org/10.1002/ijc.26321
